Coherus Oncology Inc (CHRS)

Stockholders Equity

$60.84M

Quarterly · Period ending: · USD

CHRS logo

CHRS Stockholders Equity

Latest reported$60.84M
CHRS Quarterly Shareholders Equity ($9.19M → $60.84M)
High-resolution chart · PNG

CHRS stockholders equity history

Quarterly · USD. Dates are reporting period ends; fiscal years can differ from calendar years.

Coherus Oncology Inc Stockholders Equity — Quarterly (USD)
Period endingStockholders Equity (USD)
60,838,000
78,623,000
61,014,000
87,774,000
119,827,000
-183,470,000
-131,990,000
-87,973,000
-84,108,000
-81,844,000
-193,425,000
-133,598,999
-174,764,000
-196,507,000
-137,418,000
-97,133,000
-22,629,000
12,563,000
97,726,000
130,760,000
156,220,000
127,671,000
280,974,000
255,731,000
213,377,000
157,275,000
105,214,000
56,023,000
-3,985,000
-38,515,000
-38,591,000
12,394,000
63,172,000
-1,794,000
30,535,000
56,195,000
32,140,000
78,176,000
19,354,000
32,872,000
-60,893,000
-66,006,000
-6,929,000
40,040,000
96,364,000
38,151,000
66,757,000
9,334,000
14,689,000
-60,536,000
-42,382,000
9,192,000
Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.